Skip to main content
. 2021 Feb 15;12(2):e00298. doi: 10.14309/ctg.0000000000000298

Table 2.

Univariate and multivariate logistic regression models to evaluate risk factors for infliximab cessation in the first 3 years after inclusion and anti-TNF assay testing

graphic file with name ct9-12-e00298-g007.jpg

Bold values indicates statistical significance.

CD, Crohn's disease; CI, confidence interval; IBD, inflammatory bowel disease; OR, odds ratio; TNF, tumor necrosis factor; UC, ulcerative colitis.